Elfriede Bollschweiler

Kerpener Str. 62
Koeln, NW 50924, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications

Years of Life Lost of Patients With Early Adenocarcinoma of the Esophagogastric Junction Compared to Esophageal or Gastric Adenocarcinoma. A Registry-Based Study.

Years of Life Lost of Patients With Early Adenocarcinoma of the Esophagogastric Junction Compared to Esophageal or Gastric Adenocarcinoma. A Registry-Based Study.

Journal: Cancer medicine
Published: November 07, 2025

Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach.

Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach.

Journal: Cancer medicine
Published: November 23, 2023

Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.

Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.

Journal: Updates in surgery
Published: August 04, 2022

Does VO2peak Provide a Prognostic Value in Esophagectomy and Gastrectomy for Post-operative Outcomes?

Does VO2peak Provide a Prognostic Value in Esophagectomy and Gastrectomy for Post-operative Outcomes?

Journal: In vivo (Athens, Greece)
Published: May 12, 2022

Comment on "Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma? A Propensity-matched Analysis".

Comment on "Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma? A Propensity-matched Analysis".

Journal: Annals of surgery
Published: June 25, 2021

Different response rates to chemotherapy between Japanese and German esophageal squamous cell carcinoma: patients may be influenced by ERCC1 or ABCB1.

Different response rates to chemotherapy between Japanese and German esophageal squamous cell carcinoma: patients may be influenced by ERCC1 or ABCB1.

Journal: Future oncology (London, England)
Published: July 03, 2020

Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients.

Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients.

Journal: World journal of gastroenterology
Published: December 30, 2019

Prognostic relevance of tumor response after neoadjuvant therapy for patients with esophageal cancer.

Prognostic relevance of tumor response after neoadjuvant therapy for patients with esophageal cancer.

Journal: Annals of translational medicine
Published: October 28, 2019

Propensity score-matched comparison between open and minimal invasive hybrid esophagectomy for esophageal adenocarcinoma.

Propensity score-matched comparison between open and minimal invasive hybrid esophagectomy for esophageal adenocarcinoma.

Journal: Langenbeck's archives of surgery
Published: October 12, 2019

Upregulation of miR-17-92 cluster is associated with progression and lymph node metastasis in oesophageal adenocarcinoma.

Upregulation of miR-17-92 cluster is associated with progression and lymph node metastasis in oesophageal adenocarcinoma.

Journal: Scientific reports
Published: April 08, 2019

External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer.

External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer.

Journal: Annals of surgical oncology
Published: March 01, 2019

Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?

Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?

Journal: Histopathology
Published: August 24, 2018
Showing 1-12 of 77

Last Updated: 09/26/2026